How do I initiate a norepinephrine infusion for a patient with refractory hypotension (e.g., septic or cardiogenic shock), including line placement, preparation, dosing (0.05–0.1 µg/kg/min titrated to mean arterial pressure ≥65 mmHg), and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Start a Norepinephrine Drip

Start norepinephrine at 0.02-0.05 mcg/kg/min (approximately 0.5 mg/h or 8-12 mcg/min in a 70 kg adult) via continuous IV infusion, preferably through central venous access, while simultaneously ensuring adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus, targeting a mean arterial pressure (MAP) of 65 mmHg. 1, 2, 3

Critical Pre-Administration Requirements

Address hypovolemia FIRST before starting norepinephrine by administering a minimum 30 mL/kg crystalloid bolus (approximately 2 liters in a 70 kg adult) within the first 3 hours, either before or concurrent with vasopressor initiation. 1, 3 Vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure readings. 2

In cases of profound, life-threatening hypotension (systolic BP <70 mmHg or diastolic BP ≤40 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues, rather than waiting for complete volume repletion. 2, 4, 5 Duration and depth of hypotension strongly worsen outcomes in septic shock. 5

Line Placement and Administration Route

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 1, 2, 3 However, starting norepinephrine via a large peripheral vein in a shocked patient is safe until central access is established. 1 This is particularly important because the strongest barrier to norepinephrine administration is lack of central access, and delaying treatment while obtaining central access may prolong harmful hypotension. 6

Place an arterial catheter as soon as practical for continuous blood pressure monitoring. 2, 3, 4 Monitor blood pressure and heart rate every 5-15 minutes during initial titration. 1, 2

Preparation and Concentration

Standard adult concentration: Add 4 mg of norepinephrine to 250 mL of D5W to yield a concentration of 16 mcg/mL. 2 Alternative concentration: Add 1 mg of norepinephrine to 100 mL of saline to create a 10 mcg/mL solution. 2

For pediatric patients, use the "Rule of 6": multiply 0.6 × body weight (kg) to get the number of milligrams, then dilute to 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min. 2

Initial Dosing

Adults: Start at 0.02-0.05 mcg/kg/min (approximately 0.5 mg/h or 8-12 mcg/min in a 70 kg adult). 1, 2, 3 Alternative starting range: 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70 kg adult). 2, 4

Pediatric patients: Start at 0.1 mcg/kg/min, titrating to desired clinical effect, with a typical range of 0.1-1.0 mcg/kg/min. 1, 2 Maximum doses up to 5 mcg/kg/min may be necessary in some children. 2

Pregnant patients with sepsis: Start at 0.02 mcg/kg/min with more restrictive initial fluid boluses of 1-2 L due to lower colloid oncotic pressure and higher pulmonary edema risk. 1

Target Blood Pressure and Titration

Target MAP of 65 mmHg for most patients with septic shock. 1, 2, 3 This represents the minimum threshold for adequate organ perfusion. 3

Titrate norepinephrine every 4 hours by 0.5 mg/h increments to a maximum of 3 mg/h. 2 Monitor not only MAP but also markers of tissue perfusion: lactate clearance, urine output >0.5 mL/kg/h, mental status, capillary refill ≤2 seconds, and skin perfusion. 1, 2, 3

Patients with chronic hypertension may require higher MAP targets of 70-75 mmHg to reduce the need for renal replacement therapy. 2, 3 However, targeting MAP of 85 mmHg does not improve renal function or mortality in most patients. 3

Monitoring Parameters

  • Continuous arterial blood pressure via arterial catheter 2, 3
  • Heart rate and rhythm continuously 1, 2
  • Urine output hourly (target ≥0.5 mL/kg/h) 1, 2, 3
  • Lactate levels every 2-4 hours during early resuscitation 2, 3
  • Mental status and peripheral perfusion (capillary refill, extremity temperature) 1, 2
  • Central venous pressure/oxygen saturation when available 1
  • Signs of excessive vasoconstriction: cold extremities, decreased urine output, digital ischemia, rising lactate 2, 3

Escalation Strategy for Refractory Hypotension

When norepinephrine reaches 0.1-0.25 mcg/kg/min and hypotension persists:

  1. Add vasopressin 0.03 units/min as second-line therapy rather than continuing to escalate norepinephrine alone. 1, 2, 3 Do not exceed 0.03-0.04 units/min for routine use; higher doses are reserved for salvage therapy only. 2, 3

  2. Alternative: Add epinephrine 0.1-0.5 mcg/kg/min if vasopressin is unavailable. 2, 3

  3. For persistent hypoperfusion despite adequate MAP and vasopressors: Add dobutamine 2.5-20 mcg/kg/min if there is evidence of myocardial dysfunction. 1, 2, 3

  4. For refractory shock: Consider hydrocortisone 50 mg IV every 6 hours (or 200 mg/day continuous infusion) if shock persists despite high-dose vasopressors. 1, 2, 3

Management of Extravasation

If extravasation occurs, infiltrate phentolamine 5-10 mg diluted in 10-15 mL of 0.9% sodium chloride intradermally at the site as soon as possible to prevent tissue necrosis. 2, 4 Pediatric dose: 0.1-0.2 mg/kg up to 10 mg. 2

Critical Pitfalls to Avoid

  • Never delay norepinephrine while pursuing aggressive fluid resuscitation alone in severe hypotension (systolic <70 mmHg or diastolic ≤40 mmHg). 2, 5 Early administration of norepinephrine is beneficial to restore organ perfusion and avoid fluid overload. 7, 5

  • Do not use dopamine as first-line therapy. It is associated with 11% higher absolute mortality and significantly more arrhythmias (53% risk reduction for supraventricular arrhythmias and 65% risk reduction for ventricular arrhythmias with norepinephrine vs. dopamine). 3

  • Do not use low-dose dopamine for "renal protection"—it provides no benefit and is strongly discouraged. 2, 3

  • Avoid phenylephrine as first-line therapy. It may raise blood pressure numbers while actually worsening tissue perfusion through pure alpha-agonism without cardiac support. 2, 3

  • Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions in the IV line, as adrenergic agents are inactivated in alkaline solutions. 2, 4

  • Avoid excessive fluid resuscitation. Norepinephrine increases mean systemic filling pressure and improves the fluid-induced increase in mean systemic filling pressure, potentially reducing the need for large fluid volumes. 5

Special Clinical Scenarios

Hepatorenal syndrome: Start norepinephrine at 0.5 mg/h, increasing every 4 hours by 0.5 mg/h to a maximum of 3 mg/h, with a goal to increase MAP by ≥10 mmHg and/or urine output >50 mL/h for at least 4 hours. 2

Anaphylaxis refractory to epinephrine: Use norepinephrine infusion at 0.05-0.1 mcg/kg/min for persistent hypotension after 10 minutes despite epinephrine boluses and volume resuscitation. 2, 3

Pediatric septic shock: Children commonly require 40-60 mL/kg in the first hour of fluid resuscitation. 1 Start norepinephrine at 0.1 mcg/kg/min for cold shock (poor perfusion with vasoconstriction). 1

Intraosseous administration: All intravenous medications including norepinephrine can be administered intraosseously with onset of action and drug levels comparable to venous administration. 3 Follow each medication with a saline flush to promote entry into central circulation. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Role of Pressors in Resuscitation for Treating Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.